
Curio is a healthcare technology company focused on transforming oncology care through AI-enabled solutions. Their platform offers personalized care navigation, resource aggregation, and patient education, particularly for cancer patients and those with chronic conditions. By leveraging advanced AI technology, Curio enhances care coordination and communication between healthcare providers, ensuring patients receive tailored support throughout their healthcare journey. Their mission is to empower patients and healthcare providers with data-driven insights, ultimately improving outcomes and reducing healthcare costs. Curio's commitment to compassionate care and ethical innovation positions them as a leader in the healthcare technology space, aiming to make a meaningful difference in the lives of patients.

Curio is a healthcare technology company focused on transforming oncology care through AI-enabled solutions. Their platform offers personalized care navigation, resource aggregation, and patient education, particularly for cancer patients and those with chronic conditions. By leveraging advanced AI technology, Curio enhances care coordination and communication between healthcare providers, ensuring patients receive tailored support throughout their healthcare journey. Their mission is to empower patients and healthcare providers with data-driven insights, ultimately improving outcomes and reducing healthcare costs. Curio's commitment to compassionate care and ethical innovation positions them as a leader in the healthcare technology space, aiming to make a meaningful difference in the lives of patients.
Focus: Mental health care navigation with AI-enabled education and coaching
Funding: $1,600,000.00 raised (Convertible Note, Aug 31, 2022)
Founders: Hillary Lin (CEO); Felix Li (COO); Matteo Palvarini (CTO)
Customers: Health systems and employers
Team size (snapshot): 3 employees
Mental health care navigation
Healthcare technology
1600000.00 USD
Round involved three investors; investors listed include Tiferes Ventures and Calm/Storm Ventures.
“Raised via a Convertible Note round with three investors including Tiferes Ventures and Calm/Storm Ventures.”